Stock GALENA BIOPHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Galena Biopharma Inc Nasdaq

Equities

US3632565046

Chart calendar Galena Biopharma Inc

f586acd3.5xFFBymkPLLv6NXLqqwBixYVhIX53NV_E4z5YhRuDus.vXJ9ZRHId4e6uJmpzcVR8nptwe-9poEyUL6XIHgvZrSoSAZRaOJ59YzQ5Q~5c30e465cbfaa9ff9b13996a1d57c56c

Upcoming events on Galena Biopharma Inc

03/06/2024 11:30 Shareholders Meeting
07/08/2024 Q2 2024 Earnings Release (Projected)
13/11/2024 Q3 2024 Earnings Release (Projected)
19/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Galena Biopharma Inc

Today Q1 2024 Earnings Release (Projected)
28/03/2024 20:05 Q4 2023 Earnings Release
26/03/2024 12:15 Business Update Call
03/03/2024 11:00 European School of Haematology Acute Leukaemias Conference - Abstract No:6192705
03/01/2024 13:30 Business Update Call
23/11/2023 12:00 Annual General Meeting
09/11/2023 21:04 Q3 2023 Earnings Release
04/11/2023 Global Meeting of the International Gynecologic Cancer Society
27/09/2023 14:10 Cantor Global Healthcare Conference
10/08/2023 21:08 Q2 2023 Earnings Release
21/06/2023 14:30 Maxim Group Virtual Healthcare Conference - Fireside Chat
20/06/2023 13:30 Annual General Meeting
05/06/2023 14:00 American Society of Clinical Oncology Conference - Abstract No : TPS7074
30/05/2023 13:00 Business Update Call
11/05/2023 21:12 Q1 2023 Earnings Release
16/03/2023 20:11 Q4 2022 Earnings Release
31/01/2023 13:30 Investor Meeting - Key Opinion Leader:Galinpepimut-S
12/12/2022 American Society of Hematology Meeting - Abstract #: 4263
11/12/2022 American Society of Hematology Meeting - Abstract #: 3477
07/12/2022 20:20 JMP Securities Hematology Oncology Summit

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		1,90
0,00
- 		7,60
5,07
50%		1,00
1,00
0%		0,00
13,0
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-17,2
-15,7
-9.7%		-17,0
-16,9
-0.39%		-25,3
-24,3
-4.19%		-42,0
-37,7
-11.17%		-37,9
-30,3
-24.83%
-38,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-19,4
-14,4
-34.79%		-16,8
-17,2
2.64%		-20,9
-23,4
10.57%		-41,3
-39,6
-4.25%		-37,3
-25,8
-44.54%
-40,0

Net income
Million USD		Released
Forecast
Spread 		-28,0
-19,4
-43.97%		-16,8
-17,3
2.41%		-20,7
-21,1
2.04%		-41,3
-39,6
-4.25%		-37,3
-29,8
-25.2%
-40,0

EPS
USD		Released
Forecast
Spread 		-10,9
-9,71
-12.52%		-2,11
-1,83
-15.3%		-1,34
-1,34
-0.19%		-2,13
-2,10
-1.55%		-1,34
-1,10
-21.82%
-0,90

Announcement Date13/03/2023/03/2131/03/2216/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		1,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
13,0
- 		0,00
13,0
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-11,6
-7,03
-65.32%		-6,74
-6,77
0.56%		-8,62
-7,39
-16.66%		-7,15
-8,00
10.71%		-9,45
-7,38
-27.96%		-11,3
-8,56
-31.86%		-8,84
-9,63
8.16%		-9,36
0,70
-1443.52%		-8,18
-0,64
-1168.4%
-10,0


-10,2


-10,4


-10,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,84
-6,95
1.72%		-16,7
-6,22
-169.41%		-8,41
-7,27
-15.7%		-7,02
-8,00
12.26%		-9,12
-7,17
-27.29%		-11,1
-8,51
-30.36%		-8,84
-9,56
7.49%		-9,27
0,73
-1368.15%		-8,14
3,37
-341.39%
-9,95


-9,96


-10,2


-10,5

Net income
Million USD		Released
Forecast
Spread 		-6,60
-6,95
5.12%		-16,7
-6,22
-169.41%		-8,41
-7,27
-15.7%		-7,02
-8,00
12.26%		-9,12
-7,17
-27.29%		-11,1
-8,51
-30.36%		-8,84
-9,56
7.49%		-9,27
0,73
-1368.15%		-8,14
3,37
-341.39%
-9,95


-9,96


-10,2


-10,5

EPS
USD		Released
Forecast
Spread 		-0,42
-0,40
-4.13%		-1,05
-0,38
-176.32%		-0,41
-0,39
-5.13%		-0,34
-0,39
12.07%		-0,43
-0,32
-34.38%		-0,47
-0,29
-62.07%		-0,31
-0,36
12.68%		-0,33
0,02
-1985.71%		-0,25
-0,03
-837.38%
-0,16


-0,16


-0,16


-0,13

Announcement Date31/03/2212/05/2211/08/2214/11/2216/03/2311/05/2310/08/2309/11/2328/03/24----

Upcoming sector events for Galena Biopharma Inc

Today 06:00 ARGENX SE: Q1 2024 Earnings Release
Today 07:00 VERONA PHARMA PLC: Q1 2024 Earnings Release
Today 21:01 MACROGENICS, INC.: Q1 2024 Earnings Release
Today 21:01 ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release
09/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
12/05/2024 ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
12/05/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release
12/05/2024 PEPTRON, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Galena Biopharma Inc

Today STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
Today PRIME MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
Today SAB BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today CABALETTA BIO, INC.: Q1 2024 Earnings Release (Projected)
Today ALPINE IMMUNE SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
Today SAVARA INC.: Q1 2024 Earnings Release (Projected)
Today IGM BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
Today ALTIMMUNE, INC.: Q1 2024 Earnings Release
Today RECURSION PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today SPYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. SLS Stock
  4. Stock
  5. Calendar Galena Biopharma Inc